{"id":"definity-suspension-for-injection","safety":{"commonSideEffects":[{"rate":"null","effect":"Allergic reactions"},{"rate":"null","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by producing a large number of microbubbles that are stable in the bloodstream and can be visualized with ultrasound. This allows for improved imaging of the heart and its blood vessels, which can be particularly useful in diagnosing and monitoring conditions such as coronary artery disease and cardiomyopathy.","oneSentence":"Definity Suspension for Injection is a microbubble ultrasound contrast agent that enhances the visualization of cardiac structures and function.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:31:46.778Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Echocardiography enhancement"},{"name":"Cardiac function assessment"}]},"trialDetails":[{"nctId":"NCT07314385","phase":"PHASE1","title":"NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":"Pancreatic Adenocarcinoma Metastatic, Liver Metastasis","enrollment":24},{"nctId":"NCT04185246","phase":"PHASE1, PHASE2","title":"A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography","status":"COMPLETED","sponsor":"Trust Bio-sonics, Inc.","startDate":"2019-11-04","conditions":"Cardiac Disease","enrollment":36},{"nctId":"NCT07193953","phase":"PHASE1","title":"Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-04-15","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":6},{"nctId":"NCT07179328","phase":"PHASE1","title":"Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-06-04","conditions":"GBM, Glioblastoma Multiforme (GBM), Glioblastoma Multiforme of Brain","enrollment":10},{"nctId":"NCT06815627","phase":"PHASE3","title":"Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography","status":"RECRUITING","sponsor":"Trust Bio-sonics, Inc.","startDate":"2025-03-18","conditions":"Cardiac Diseases","enrollment":150},{"nctId":"NCT05135169","phase":"","title":"Multi-organ Transit Time Acquisition Using Contrast Ultrasound","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-03-03","conditions":"Healthy","enrollment":16},{"nctId":"NCT06633601","phase":"PHASE1","title":"MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast Cancer","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-07-01","conditions":"Breast Cancer","enrollment":30},{"nctId":"NCT05482321","phase":"","title":"Pancreas Ultrasound Imaging in type1 Diabetes","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-02-27","conditions":"Type1diabetes, Insulitis, Pancreas Inflamed","enrollment":50},{"nctId":"NCT05613946","phase":"PHASE1","title":"Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-12-15","conditions":"Lymphedema Arm","enrollment":10},{"nctId":"NCT03740997","phase":"PHASE4","title":"Study to Determine Safety and Dosage of OPTISON in Pediatric Participants","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2020-12-01","conditions":"Transthoracic Echocardiography, Suspected or Known Structural or Functional Cardiac Abnormality","enrollment":39},{"nctId":"NCT02384473","phase":"EARLY_PHASE1","title":"Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2014-12-24","conditions":"Adult Soft Tissue Sarcoma, Bone Sarcoma, Retroperitoneal Sarcoma","enrollment":25},{"nctId":"NCT04431674","phase":"PHASE1","title":"Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Chest-wall and Breast Cancer","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-07-22","conditions":"Breast Cancer","enrollment":20},{"nctId":"NCT02170103","phase":"NA","title":"Microvascular Recovery With Ultrasound in Myocardial Infarction (MRUSMI) Post PCI Trial","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2018-09-16","conditions":"STEMI, Chest Pain","enrollment":50},{"nctId":"NCT02102243","phase":"PHASE4","title":"Neural Mechanism of Aldosterone-induced Insulin Resistance","status":"WITHDRAWN","sponsor":"Wanpen Vongpatanasin","startDate":"2010-11","conditions":"Hypertension","enrollment":""},{"nctId":"NCT00162370","phase":"PHASE4","title":"A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2004-04","conditions":"Coronary Artery Disease, Heart Disease","enrollment":400},{"nctId":"NCT00625365","phase":"PHASE4","title":"A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2008-02","conditions":"Cardiovascular Disease","enrollment":1060},{"nctId":"NCT02880137","phase":"PHASE4","title":"Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-09","conditions":"Cardiac Allograft Vasculopathy","enrollment":36},{"nctId":"NCT01242020","phase":"NA","title":"Microvascular Flow Assessment Repeatability Study: The MARS Study","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2011-01","conditions":"Obesity","enrollment":6},{"nctId":"NCT02321527","phase":"NA","title":"Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-07","conditions":"Breast Cancer","enrollment":21},{"nctId":"NCT02233725","phase":"PHASE1","title":"MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2014-07","conditions":"Prostatic Neoplasms","enrollment":50},{"nctId":"NCT01394926","phase":"PHASE2","title":"Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease","status":"TERMINATED","sponsor":"GE Healthcare","startDate":"2011-06","conditions":"Carotid Artery Disease","enrollment":21},{"nctId":"NCT00239525","phase":"NA","title":"3-D Transcranial Ultrasound Analysis Study","status":"COMPLETED","sponsor":"Duke University","startDate":"2006-05","conditions":"Cerebrovascular Accident, Intracranial Hypertension","enrollment":28},{"nctId":"NCT00878878","phase":"PHASE4","title":"Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2009-03","conditions":"Pulmonary Hypertension","enrollment":30},{"nctId":"NCT00730964","phase":"PHASE4","title":"A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2008-05","conditions":"Echocardiography","enrollment":1039},{"nctId":"NCT00162058","phase":"PHASE2","title":"A Phase II Study of DMP 115 to Assess Focal Liver Lesions","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2004-03","conditions":"Liver Disease","enrollment":80},{"nctId":"NCT00401687","phase":"PHASE4","title":"DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2006-07","conditions":"Ventricular Ejection Fraction","enrollment":131}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Perflutren Lipid Microsphere","Microbubbles","DEFINITY"],"phase":"phase_2","status":"active","brandName":"Definity Suspension for Injection","genericName":"Definity Suspension for Injection","companyName":"Sunnybrook Health Sciences Centre","companyId":"sunnybrook-health-sciences-centre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Definity Suspension for Injection is a microbubble ultrasound contrast agent that enhances the visualization of cardiac structures and function. Used for Echocardiography enhancement, Cardiac function assessment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}